Immun4Cure will host the 2nd International Immunotherapy Symposium in Montpellier from 25–27 November 2026.
SIRIC Montpellier Cancer is delighted to support the session on Metabolic Signatures in Cancer Immunotherapy, taking place on Thursday 26 November afternoon and moderated by Nathalie Bonnefoy from IRCM – Institut de Recherche en Cancérologie de Montpellier and Dalil Hannani from Université Grenoble Alpes.
Over three days, the symposium will address key challenges and opportunities in immunotherapy, including Treg-based therapies, CAR-T and T-cell engagers, RNA therapeutics and vaccination strategies, and metabolic signatures in cancer immunotherapy.
Sessions dedicated to therapeutic innovations in autoimmunity and inflammatory diseases, artificial intelligence, and patient engagement will provide a multidisciplinary perspective on the future of immunotherapies.
📌 More information and the full programme are available here: https://lnkd.in/eNTQcaZ5
